Clinical Trial Update: Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing intraperitoneal paclitaxel, doxorubicin hydrochloride, and cisplatin for stage III-IV endometrial cancer. The study sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Uterine Corpus Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma | Phase 1 | Status: COMPLETED